Cali, Ignazio
Lavrich, Jody
Moda, Fabio
Kofskey, Diane
Nemani, Satish Kumar
Appleby, Brian
Tagliavini, Fabrizio
Soto, Claudio
Gambetti, Pierluigi
Notari, Silvio
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (5P01AI106705, 5P01AI106705)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (5R01NS083687)
Britton Fund (Charles S. Britton Fund)
Article History
Received: 6 November 2018
Accepted: 14 March 2019
First Online: 26 March 2019
Competing Interests
: Dr. Soto is inventor on several patents related to the PMCA technology and is currently Founder, Chief Scientific Officer and Vice-President of Amprion Inc, a biotech company focusing on the commercial utilization of PMCA for prion diagnosis.